المدينة
المدينة
Ready to play
Ready to play
Australia has announced a breakthrough in Alzheimer’s disease diagnosis through the development of blood tests based on biomarkers such as p-tau217 and p-tau181 proteins, which enable early detection of brain changes associated with the disease with high accuracy. This achievement resulted from a collaboration between the Australian Neuroscience Research Centre and Roche Diagnostics to establish a specialized center dedicated to this purpose, where test results can be obtained within approximately 18 minutes. These tests are used as part of a comprehensive medical assessment, and researchers hope they will contribute to early diagnosis, thereby supporting improved patient care and treatment. It is expected that their use will expand within the Australian healthcare system in the coming period.
Notice: This Is an AI-Generated Summary
Comments (0)